Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis

2020203 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov Identifier: NCT02672852.

Good health and well-being

Published in: JAMA Dermatology

Volume 156, Issue 6, pp. 649-649

Field-Weighted Citation Impact: 10.40